Quintiles (Q) Tops Q1 EPS by 3c

Go back to Quintiles (Q) Tops Q1 EPS by 3c

Citi Downgrades Quintiles (Q) to Neutral

May 4, 2016 8:53 AM EDT

Citi downgraded Quintiles (NYSE: Q) from Buy to Neutral.

For an analyst ratings summary and ratings history on Quintiles click here. For more ratings news on Quintiles click here.

Shares of Quintiles closed at $67.46 yesterday.

... More

Evercore ISI Downgrades Quintiles (Q) to Hold

May 4, 2016 7:01 AM EDT

Evercore ISI downgraded Quintiles (NYSE: Q) from Buy to Hold with a price target of $74.00.

Analyst Ross J. Muken said they are positive on the IMS transaction in the longer term, but near term dynamics cause us to downgrade.

Near-term dynamics... More

Baird Downgrades Quintiles (Q) to Neutral

May 4, 2016 6:55 AM EDT

Baird downgraded Quintiles (NYSE: Q) from Outperform to Neutral with a price target of $74.00 (from $76.00).

For an analyst ratings summary and ratings history on Quintiles click here. For more ratings news on Quintiles click here.

Shares of Quintiles closed at $67.46 yesterday.

... More

IMS Health (IMS), Quintiles (Q) Enter Merger Agreement; Carries Enterprise Value of $23B

May 3, 2016 6:11 AM EDT

IMS Health Holdings, Inc. (NYSE: IMS) and Quintiles Transnational Holdings Inc. (NYSE: Q) announced today that their respective boards of directors approved a definitive merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction. The merged company will be named Quintiles IMS Holdings, Inc. Based on the closing of IMS Health and Quintiles common stock prices on May 2, 2016, the equity market capitalization of the joined companies is more than $17.6 billion and the enterprise value is more than $23 billion. The 2015 pro forma reported... More